Adagio Medical is a developmental stage medical device company located in Laguna Hills, California and focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
Company profile
Ticker
ADGM
Exchange
CEO
Mr. Olav B. Bergheim
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Aja Holdco, Inc.
SEC CIK
ADGM stock data
Latest filings (excl ownership)
8-K/A
Financial Statements and Exhibits
4 Nov 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
1 Nov 24
S-8
Registration of securities for employees
8 Oct 24
EFFECT
Notice of effectiveness
20 Sep 24
EFFECT
Notice of effectiveness
20 Sep 24
424B3
Prospectus supplement
19 Sep 24
424B3
Prospectus supplement
19 Sep 24
S-1
IPO registration
13 Sep 24
S-1
IPO registration
13 Sep 24
10-Q
2024 Q2
Quarterly report
26 Aug 24
Latest ownership filings
Financial summary
| Quarter (USD) | Jun 24 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
Institutional ownership, Q2 2024
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Sep 24 | Sciences Holdings IV ARYA | Common Stock | Other | Dispose J | No | No | 0 | 3,501,600 | 0.00 | 0 |
Press releases
Adagio Medical to Present at the Stifel 2024 Healthcare Conference
4 Nov 24
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
24 Oct 24
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
7 Oct 24